007HO10582 PAUL

Print/PDF
Registration Name ENSENADA JEEVES PAUL-ET
Registration Number HOUSA000066451345
Primary NAAB Code 007HO10582
Secondary Code(s)
Status Inactive
Controller Name Select Sires (7)
Date of Birth 1/12/2009
aAa -
DMS -
GFI 6.9%
Genetic Codes * TR TV TL TY TD
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HCD-T
Sire KED OUTSIDE JEEVES-ET
MGS PICSTON SHOTTLE-ET
Beta Casein A2A2
Kappa Casein AA
Beta Lactoglobulin AA
INDEXES
NM$ -267, 92% R CM$ -260
NM Percentile 11% FM$ -281
GTPI 2165 GM$ -281
PRODUCTION TRAITS
2810 Dtrs 806 herds 81 % US 99% R
Milk -811 Fat, % -50 , -0.06%
SCS 2.92, 99% R Protein, % -21 , +0.02%
Feed Saved -32 , 60% R Milking Speed 6.87 , 76% R
Health & Fertility
Productive Life 1.7      98% R Mastitis 2.0      95% R
Heifer Livability 0.6       82% R Metritis -2.0      91% R
Livability 2.7      95% R D. Abom -1.3      95% R
DPR 1.9      99% R Ketosis -1.7      90% R
FSC -2.3      99% R R. Placenta -0.3      92% R
HCR 2.6      95% R Milk Fever 0.1      83% R
CCR 0.5      99% R
SCR -        -
DIA 0.8      57% R
RSP 0.7      66% R
Calving Traits
Sire CE 2.0      98% R 3054 Obs
Daughter CE 2.9      97% R 2696 Obs, 1396 Dtrs
Sire SB 5.0      96% R 2886 Obs
Daughter SB 5.4      96% R 2371 Obs, Dtrs
Gestation Length 0.8      99% R 552 Obs, 3170 Dtrs
Early First Calving 4.2      98% R 587 Obs, 2145 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
613 Dtrs 240 herds 98% R
PTA Type -0.85 UDC -1.11
HCC -0.39 BWC -0.76
FLC 0.63
Linear Traits
Stature -1.58
Short
Strength -0.95
Weak
Body Depth -0.97
Shallow
Dairy Form -0.95
Closed
Rump Angle 0.62
Sloped
Thurl Width -0.49
Sloped
Rear Legs-Side View -0.49
Narrow
Rear Legs-Rear View 0.58
Straight
Foot Angle -0.51
Low
Feet & Legs Score 0.22
High
F.U. Attachment -0.54
Straight
Rear Udder Height -1.87
Low
Rear Udder Width -1.46
Narrow
Udder Cleft -1.06
Weak
Udder Depth 0.58
Straight
Front Teat Placement -0.77
Wide
Rear Teat Placement -1.10
Wide
Teat Length -1.03
Short
-2
0
2

CDCB August 2026; Base of Evaluation: HO